Janssen Dx Couples Cellsearch System with Asuragen NGS Panels to Characterize Circulating Tumor Cells
NEW YORK (GenomeWeb) — Janssen Diagnostics said last week that it is now offering research services on its Cellsearch system for circulating tumor cell preparation in conjunction with Asuragen's SuraSeq next-generation sequencing cancer panels.
Veridex, Arno Reach Deal to Develop CDx for Anti-Progestins
NEW YORK (GenomeWeb News) – Arno Therapeutics today announced an agreement with Johnson & Johnson's Veridex to develop a companion diagnostic for identifying patients who may benefit from anti-progestin cancer therapeutics.
LabCorp Offering Veridex's CTC Test for Clinical Trials Research in China
NEW YORK (GenomeWeb News) – Veridex announced this week a deal with Laboratory Corporation of America to make its CellSearch circulating tumor cell test available in China.
China Approves Veridex's CellSearch Test for Metastatic Breast Cancer
NEW YORK (GenomeWeb News) – Chinese regulators approved Veridex's CellSearch circulating tumor test for aiding in the diagnosis of women with metastatic breast cancer, Veridex announced on Wednesday.
Lab Industry, Pathologists Still at Odds Over Fee Schedule for New Molecular Pathology CPT Codes
At a meeting hosted by the Centers for Medicare & Medicaid Services this week to determine payment levels for genetic tests placed in the clinical laboratory fee schedule, lab industry professionals remained at loggerheads with pathologists who maintained that the physician f
May 22, 2012
Apr 23, 2012
Veridex, Novartis Partner on CTC Research
Mar 15, 2011
Dec 15, 2010
MDxHealth Amends Biomarker Pact with Veridex
Apr 7, 2009